Products for Research Use Only
RegisterLogin

CB1 antagonist 2

CAT: 0804-HY-116649-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-116649-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM[1].
CAS Number
614726-85-1
Product Name Alternative
AM4113
UNSPSC
12352005
Target
Cannabinoid Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/cb1-antagonist-2.html
Purity
99.91
Solubility
DMSO : 62.5 mg/mL (ultrasonic)
Smiles
O=C(N)C1=NN(C(C2=CC=C(C=C2)Cl)=C1C)C3=CC=C(C=C3Cl)Cl
Molecular Formula
C17H12Cl3N3O
Molecular Weight
380.66
References & Citations
[1]Song Li, et al. 4-methyl-diaryl -1H- pyrazole derivatives and their use as medicamentsFIELD.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-U00397CB1 antagonist 1
HY-178857CB1 antagonist 6
HY-120653-01CB1 antagonist 5
HY-112340-01CB1 antagonist 4
HY-147821CB1-IN-2
HY-172409CB1R antagonist 2
HY-150028CB1/2 agonist 2
HY-147512-01CB1/2 agonist 1
HY-150029-01CB1/2 agonist 3
HY-150030CB1/2 agonist 4

Alternative Products

CatalogName
TBI2441-250MGPranlukast, Leukotriene CysLT1 antagonist; GPR17 antagonist
TBI2597-50MGMontelukast, Leukotriene CysLT1 antagonist; GPR17 antagonist
cyt-538-01chGH Antagonist
cyt-215-01oGH Antagonist
4031352.0500VIP Antagonist
H-8650.0005PDGF Antagonist
JLB39188-01Vasopressin antagonist
254641Antagonist G
T36127-01TNF-α Antagonist
sc-221406BCCR4 Antagonist

Popular Products